IL111393A0 - New ribosome-inactivating protein isolated from the plant byronia dioica - Google Patents
New ribosome-inactivating protein isolated from the plant byronia dioicaInfo
- Publication number
- IL111393A0 IL111393A0 IL11139394A IL11139394A IL111393A0 IL 111393 A0 IL111393 A0 IL 111393A0 IL 11139394 A IL11139394 A IL 11139394A IL 11139394 A IL11139394 A IL 11139394A IL 111393 A0 IL111393 A0 IL 111393A0
- Authority
- IL
- Israel
- Prior art keywords
- plant
- protein isolated
- inactivating protein
- new ribosome
- byronia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14189193A | 1993-10-25 | 1993-10-25 | |
US08/324,301 US5597569A (en) | 1993-10-25 | 1994-10-20 | Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
Publications (1)
Publication Number | Publication Date |
---|---|
IL111393A0 true IL111393A0 (en) | 1995-03-30 |
Family
ID=26839543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11139394A IL111393A0 (en) | 1993-10-25 | 1994-10-25 | New ribosome-inactivating protein isolated from the plant byronia dioica |
Country Status (7)
Country | Link |
---|---|
US (1) | US5597569A (fr) |
EP (1) | EP0725823A1 (fr) |
JP (1) | JPH09509043A (fr) |
AU (1) | AU684571B2 (fr) |
CA (1) | CA2174943A1 (fr) |
IL (1) | IL111393A0 (fr) |
WO (1) | WO1995011977A2 (fr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69522216T2 (de) * | 1994-05-13 | 2002-05-02 | Biovation Ltd | Zielzellen-bindende chimäre Peptide |
US5541110A (en) * | 1994-05-17 | 1996-07-30 | Bristol-Myers Squibb | Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica |
US6410690B1 (en) * | 1995-06-07 | 2002-06-25 | Medarex, Inc. | Therapeutic compounds comprised of anti-Fc receptor antibodies |
IT1286663B1 (it) * | 1996-06-27 | 1998-07-15 | Ministero Uni Ricerca Scient E | Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna |
AU8040898A (en) | 1997-06-06 | 1998-12-21 | Tanox Pharma B.V. | Type-1 ribosome-inactivating protein |
DE19740180A1 (de) * | 1997-09-12 | 1999-03-18 | Basf Ag | Katalysator, umfassend wenigstens einen Nickel(0)Komplex auf Basis eines Phosphonitliganden und Verfahren zur Herstellung von Nitrilen |
US6251392B1 (en) * | 1997-10-20 | 2001-06-26 | Epicyte Pharmaceuticals, Inc. | Epithelial cell targeting agent |
MXPA01001445A (es) * | 1998-08-11 | 2002-11-29 | Large Scale Biology Corp | Metodo para recuperar proteinas a partir del fluido intersticial de tejidos de plantas. |
US6946129B1 (en) * | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
US20010051147A1 (en) * | 2000-03-27 | 2001-12-13 | Van De Winkel Jan G.J. | Methods for immunostimulation using binding agents for the Fc receptor of immunoglobulin A |
US7622446B2 (en) * | 2001-04-18 | 2009-11-24 | The Open University | Polypeptides, derivatives and uses thereof |
US7491702B2 (en) * | 2001-04-18 | 2009-02-17 | The Open University | Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same |
CN1946425B (zh) * | 2004-02-27 | 2012-10-03 | 免疫系统治疗有限公司 | B细胞疾病的靶 |
ATE485057T1 (de) * | 2005-05-26 | 2010-11-15 | Seattle Genetics Inc | Humanisierte antikörper gegen cd40 und verfahren zu ihrer anwendung |
AU2008294074B2 (en) | 2007-08-30 | 2015-01-22 | Walter And Eliza Hall Institute Of Medical Research | Dendritic cell marker and uses thereof |
WO2009039584A1 (fr) | 2007-09-28 | 2009-04-02 | Welcome Receptor Antibodies Pty Ltd | Diagnostic et traitement d'un tissu atteint de maladie et lésé |
EP2864362A4 (fr) * | 2012-06-26 | 2015-11-18 | Biovalence Sdn Bhd | Traitement anticancéreux |
AU2013281395A1 (en) * | 2012-06-26 | 2015-02-05 | Biovalence Sdn. Bhd. | Dosage regime of fusion compounds |
WO2023196892A1 (fr) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Immunisation passive avec des anticorps neutralisants anti-aav pour empêcher la transduction hors cible de vecteurs aav administrés par voie intrathécale |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8619830D0 (en) * | 1986-08-14 | 1986-09-24 | Erba Farmitalia | Inhibitor of protein synthesis |
NL8701095A (nl) * | 1987-05-08 | 1988-12-01 | Nido Universal Machines Bv | Loopwiel voor een strooi-inrichting. |
IT1229216B (it) * | 1989-03-31 | 1991-07-25 | Italfarmaco Spa | Proteine inibenti i ribosomi e loro derivati. |
IL94872A (en) * | 1989-06-30 | 1995-03-30 | Oncogen | Monoclonal or chimeric antibodies that react with human carcinoma, recombinant proteins that contain their anti-binding site, pharmaceutical preparations and kits that contain the |
US5242813A (en) * | 1990-10-12 | 1993-09-07 | The United States Of America As Represented By The Department Of Health And Human Services | Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
-
1994
- 1994-10-20 US US08/324,301 patent/US5597569A/en not_active Expired - Fee Related
- 1994-10-25 JP JP7512852A patent/JPH09509043A/ja active Pending
- 1994-10-25 IL IL11139394A patent/IL111393A0/xx unknown
- 1994-10-25 CA CA002174943A patent/CA2174943A1/fr not_active Abandoned
- 1994-10-25 EP EP94932092A patent/EP0725823A1/fr not_active Withdrawn
- 1994-10-25 WO PCT/US1994/012382 patent/WO1995011977A2/fr not_active Application Discontinuation
- 1994-10-25 AU AU80945/94A patent/AU684571B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP0725823A1 (fr) | 1996-08-14 |
JPH09509043A (ja) | 1997-09-16 |
AU684571B2 (en) | 1997-12-18 |
AU8094594A (en) | 1995-05-22 |
WO1995011977A3 (fr) | 1995-05-26 |
CA2174943A1 (fr) | 1995-05-04 |
WO1995011977A2 (fr) | 1995-05-04 |
US5597569A (en) | 1997-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2269176B (en) | Peptides | |
IL111393A0 (en) | New ribosome-inactivating protein isolated from the plant byronia dioica | |
GB9507319D0 (en) | Plant tender | |
EP0701446A4 (fr) | Peptides hemoregulateurs | |
EP0578819A4 (fr) | Proteine apparentee a icam. | |
PL309778A1 (en) | Novel peptides | |
IL110938A0 (en) | Plant proteins | |
EP0679658A4 (fr) | Peptide a effet antagoniste de l'endotheline. | |
GB9325519D0 (en) | Peptides | |
IL108353A0 (en) | Novel peptides | |
GB9320930D0 (en) | Modified fruit | |
ZA941081B (en) | Pesticides | |
GB2279703B (en) | Variable area outlet | |
ZA934353B (en) | Linear peptides. | |
GB9204274D0 (en) | Novel peptides | |
EP0561439A3 (en) | Ersions | |
EP0725651A4 (fr) | Peptides hemoregulateurs | |
ZA944947B (en) | Pesticides | |
GB9313891D0 (en) | Pesticides | |
EP0672680A4 (fr) | Nouveau peptide. | |
GB9311346D0 (en) | Modified fruit | |
KR960007545Y1 (en) | Outlet trap | |
GB9210074D0 (en) | Peptides | |
ZA935126B (en) | Peptides | |
ZA94211B (en) | Peptides |